Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
Department of Neurosurgery, The National Hospital for Neurology and Neurosurgery, London, UK.
Pituitary. 2023 Dec;26(6):645-652. doi: 10.1007/s11102-023-01357-w. Epub 2023 Oct 16.
Heterogeneous reporting in baseline variables in patients undergoing transsphenoidal resection of pituitary adenoma precludes meaningful meta-analysis. We therefore examined trends in reported baseline variables, and degree of heterogeneity of reported variables in 30 years of literature.
A systematic review of PubMed and Embase was conducted on studies that reported outcomes for transsphenoidal surgery for pituitary adenoma 1990-2021. The protocol was registered a priori and adhered to the PRISMA statement. Full-text studies in English with > 10 patients (prospective), > 500 patients (retrospective), or randomised trials were included.
178 studies were included, comprising 427,659 patients: 52 retrospective (29%); 118 prospective (66%); 9 randomised controlled trials (5%). The majority of studies were published in the last 10 years (71%) and originated from North America (38%). Most studies described patient demographics, such as age (165 studies, 93%) and sex (164 studies, 92%). Ethnicity (24%) and co-morbidities (25%) were less frequently reported. Clinical baseline variables included endocrine (60%), ophthalmic (34%), nasal (7%), and cognitive (5%). Preoperative radiological variables were described in 132 studies (74%). MRI alone was the most utilised imaging modality (67%). Further specific radiological baseline variables included: tumour diameter (52 studies, 39%); tumour volume (28 studies, 21%); cavernous sinus invasion (53 studies, 40%); Wilson Hardy grade (25 studies, 19%); Knosp grade (36 studies, 27%).
There is heterogeneity in the reporting of baseline variables in patients undergoing transsphenoidal surgery for pituitary adenoma. This review supports the need to develop a common data element to facilitate meaningful comparative research, trial design, and reduce research inefficiency.
接受经蝶窦垂体腺瘤切除术的患者的基线变量报告存在异质性,从而妨碍了有意义的荟萃分析。因此,我们检查了 30 年来报告的基线变量趋势以及报告变量的异质性程度。
对 1990 年至 2021 年期间报告经蝶窦手术治疗垂体腺瘤结果的 PubMed 和 Embase 进行了系统回顾。该方案是事先注册的,并遵守 PRISMA 声明。纳入标准为:英文全文研究,患者数>10 例(前瞻性)、>500 例(回顾性)或随机试验;纳入标准为:纳入研究均为前瞻性或回顾性,或随机对照试验。
共纳入 178 项研究,包括 427659 例患者:52 项回顾性研究(29%);118 项前瞻性研究(66%);9 项随机对照试验(5%)。大多数研究发表于过去 10 年(71%),来自北美(38%)。大多数研究描述了患者的人口统计学特征,如年龄(165 项研究,93%)和性别(164 项研究,92%)。种族(24%)和合并症(25%)较少报告。临床基线变量包括内分泌(60%)、眼科(34%)、鼻腔(7%)和认知(5%)。132 项研究(74%)描述了术前影像学变量。单独使用 MRI 是最常用的成像方式(67%)。进一步的具体基线影像学变量包括:肿瘤直径(52 项研究,39%);肿瘤体积(28 项研究,21%);海绵窦侵袭(53 项研究,40%);Wilson Hardy 分级(25 项研究,19%);Knosp 分级(36 项研究,27%)。
接受经蝶窦垂体腺瘤切除术的患者的基线变量报告存在异质性。本综述支持需要制定一个通用数据元素,以促进有意义的比较研究、试验设计,并减少研究效率低下。